CSCasey M. Silver

Casey M. Silver

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Casey M. Silver has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Re-triage of severely injured patients in no-fault vs. at-fault states

    by Michael R. Visenio, Neil Thivalapill, Casey M. Silver, Gwyneth A. Sullivan, Arielle C. Thomas, Susheel Reddy, Mira Ghneim, Jessica L. Ryan, Etienne L. Pracht, Marie L. Crandall, et al.

  • Top Cited Papers
    Open Access

    Morbidity and Length of Stay After Injury Among People Experiencing Homelessness in North America

    by Casey M. Silver, Arielle C. Thomas, Susheel Reddy, Shelbie Kirkendoll, Avery B. Nathens, Nabil Issa, Purvi P. Patel, Rebecca E. Plevin, Hemal K. Kanzaria, Anne M. Stey

    Importance: Traumatic injury is a leading cause of hospitalization among people experiencing homelessness. However, hospital course among this population is unknown.Objective: To evaluate whether homelessness was associated with increased morbidity and length of stay (LOS) after hospitalization for traumatic injury and whether associations between homelessness and LOS were moderated by age and/or Injury Severity Score (ISS).Design, Setting, and Participants: This retrospective cohort study of the American College of Surgeons Trauma Quality Programs (TQP) included patients 18 years or older who were hospitalized after an injury and discharged alive from 787 hospitals in North America from January 1, 2017, to December 31, 2018. People experiencing homelessness were propensity matched to housed patients for hospital, sex, insurance type, comorbidity, injury mechanism type, injury body region, and Glasgow Coma Scale score. Data were analyzed from February 1, 2022, to May 31, 2023.Exposures: People experiencing homelessness were identified using the TQP’s alternate home residence variable.Main Outcomes and Measures: Morbidity, hemorrhage control surgery, and intensive care unit (ICU) admission were assessed. Associations between homelessness and LOS (in days) were tested with hierarchical multivariable negative bionomial regression. Moderation effects of age and ISS on the association between homelessness and LOS were evaluated with interaction terms.Results: Of 1 441 982 patients (mean [SD] age, 55.1 [21.1] years; (822 491 [57.0%] men, 619 337 [43.0%] women, and 154 [0.01%] missing), 9065 (0.6%) were people experiencing homelessness. Unmatched people experiencing homelessness demonstrated higher rates of morbidity (221 [2.4%] vs 25 134 [1.8%]; P < .001), hemorrhage control surgery (289 [3.2%] vs 20 331 [1.4%]; P < .001), and ICU admission (2353 [26.0%] vs 307 714 [21.5%]; P < .001) compared with housed patients. The matched cohort comprised 8665 pairs at 378 hospitals. Differences in rates of morbidity, hemorrhage control surgery, and ICU admission between people experiencing homelessness and matched housed patients were not statistically significant. The median unadjusted LOS was 5 (IQR, 3-10) days among people experiencing homelessness and 4 (IQR, 2-8) days among matched housed patients (P < .001). People experiencing homelessness experienced a 22.1% longer adjusted LOS (incident rate ratio [IRR], 1.22 [95% CI, 1.19-1.25]). The greatest increase in adjusted LOS was observed among people experiencing homelessness who were 65 years or older (IRR, 1.42 [95% CI, 1.32-1.54]). People experiencing homelessness with minor injury (ISS, 1-8) had the greatest relative increase in adjusted LOS (IRR, 1.30 [95% CI, 1.25-1.35]) compared with people experiencing homelessness with severe injury (ISS ≥16; IRR, 1.14 [95% CI, 1.09-1.20]).Conclusions and Relevance: The findings of this cohort study suggest that challenges in providing safe discharge to people experiencing homelessness after injury may lead to prolonged LOS. These findings underscore the need to reduce disparities in trauma outcomes and improve hospital resource use among people experiencing homelessness.


  • Transitional care programs for trauma patients: A scoping review

    by Francesca M. Shilati, Casey M. Silver, Archit Baskaran, Angie Jang, Q. Eileen Wafford, John Slocum, Christine Schilling, Christine Schaeffer, Michael B. Shapiro, Anne M. Stey


  • Open Access

    Injury Patterns and Hospital Admission After Trauma Among People Experiencing Homelessness

    by Casey M. Silver, Arielle C. Thomas, Susheel Reddy, Gwyneth A. Sullivan, Rebecca E. Plevin, Hemal K. Kanzaria, Anne M. Stey

    An estimated 580 000 people experienced homelessness in the US on any given night in 2020, with increasing volume during the COVID-19 pandemic.1 Lack of stable housing is an important health-related social risk factor.2,3 People experiencing homelessness (PEH) face substantial barriers to primary care, resulting in higher rates of emergency department (ED) utilization.4-8 PEH also have increased mortality rates compared with the general population.9-11


  • Evaluation of emergency department treat‐and‐release encounters after major gastrointestinal surgery

    by Brian C. Brajcich, Julie K. Johnson, Jane L. Holl, Karl Y. Bilimoria, Meagan S. Ager, Jeanette Chung, Rachel Hae Soo Joung, Cassandra B. Iroz, David D. Odell, David J. Bentrem, et al.

    Background and Objectives: Emergency department (ED) utilization after gastrointestinal cancer operations is poorly characterized. Our study objectives were to determine the incidence of, reasons for, and predictors of ED treat‐and‐release encounters after gastrointestinal cancer operations.Methods: Patients who underwent elective esophageal, hepatobiliary, gastric, pancreatic, small intestinal, or colorectal operations for cancer were identified in the 2015–2017 Healthcare Cost and Utilization Project State Inpatient and State Emergency Department Databases for New York, Maryland, and Florida. The primary outcomes were the incidence of ED treat‐and‐release encounters and readmissions within 30 days of discharge.Results: Among 51 527 patients at 406 hospitals, 4047 (7.9%) had an ED treat‐and‐release encounter, and 5573 (10.8%) had an ED encounter with readmission. In total, 40.7% of ED encounters were treat‐and‐release encounters. ED treat‐and‐release encounters were most frequently for pain (12.0%), device/ostomy complaints (11.7%), or wound complaints (11.4%). ED treat‐and‐release encounters predictors included non‐Hispanic Black race/ethnicity (odds ratio [OR] 1.24, 95% confidence interval [CI] 1.12–1.37) and Medicare (OR 1.27, 95% CI 1.16–1.40) or Medicaid (OR 1.82, 95% CI 1.62–2.40) coverage.Conclusions: ED treat‐and‐release encounters are common after major gastrointestinal operations, making up nearly half of postdischarge ED encounters. The reasons for ED treat‐and‐release encounters differ from those for ED encounters with readmissions.


  • Hospital variability in adoption of alcohol and drug screening in adult trauma patients

    by Casey M. Silver, Michael R. Visenio, Arielle C. Thomas, Susheel Reddy, Maria C. Raven, Hemal K. Kanzaria, Rebecca E. Plevin, Anne M. Stey

    BACKGROUND Despite recommendations to screen all injured patients for substance use, single-center studies have reported underscreening. This study sought to determine if there was significant practice variability in adoption of alcohol and drug screening of injured patients among hospitals participating in the Trauma Quality Improvement Program. METHODS This was a retrospective observational cross-sectional study of trauma patients 18 years or older in Trauma Quality Improvement Program 2017–2018. Hierarchical multivariable logistic regression modeled the odds of screening for alcohol and drugs via blood/urine test while controlling for patient and hospital variables. We identified statistically significant high and low-screening hospitals based on hospitals' estimated random intercepts and associated confidence intervals (CIs). RESULTS Of 1,282,111 patients at 744 hospitals, 619,423 (48.3%) were screened for alcohol, and 388,732 (30.3%) were screened for drugs. Hospital-level alcohol screening rates ranged from 0.8% to 99.7%, with a mean rate of 42.4% (SD, 25.1%). Hospital-level drug screening rates ranged from 0.2% to 99.9% (mean, 27.1%; SD, 20.2%). A total of 37.1% (95% CI, 34.7–39.6%) of variance in alcohol screening and 31.5% (95% CI, 29.2–33.9%) of variance in drug screening were at the hospital level. Level I/II trauma centers had higher adjusted odds of alcohol screening (adjusted odds ratio [aOR], 1.31; 95% CI, 1.22–1.41) and drug screening (aOR, 1.16; 95% CI, 1.08–1.25) than Level III and nontrauma centers. We found 297 low-screening and 307 high-screening hospitals in alcohol after adjusting for patient and hospital variables. There were 298 low-screening and 298 high-screening hospitals for drugs. CONCLUSION Overall rates of recommended alcohol and drug screening of injured patients were low and varied significantly between hospitals. These results underscore an important opportunity to improve the care of injured patients and reduce rates of substance use and trauma recidivism. LEVEL OF EVIDENCE Prognostic and Epidemiological; Level III. Export


  • Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma

    by Casey M. Silver, Rachel H. Joung, Charles D. Logan, Al B. Benson, Devalingam Mahalingam, Michael I. D'ANgelica, David J. Bentrem, Anthony D. Yang, Karl Y. Bilimoria, Ryan P. Merkow

    Background and Objectives: Evidence for neoadjuvant therapy (NAT) in extrahepatic cholangiocarcinoma (eCCA) is limited. Our objectives were to: (1) characterize treatment trends, (2) identify factors associated with receipt of NAT, and (3) evaluate associations between NAT and postoperative outcomes.Methods: Retrospective cohort study of the National Cancer Database (2004–2017). Multivariable logistic regression assessed associations between NAT and postoperative outcomes. Stratified analysis evaluated differences between surgery first, neoadjuvant chemotherapy, and neoadjuvant chemoradiation (CRT).Results: Among 8040 patients, 417 (5.2%) received NAT. NAT increased during the study period 2.9%–8.4% (p < 0.001). Factors associated with receipt of NAT included age 75, odds ratio [OR] 4.32, p < 0.001) and stage 3 disease (vs. 1, OR 1.68, p = 0.01). Compared with surgery first, patients who received NAT had higher odds of R0 resection (OR 1.49, p = 0.01) and lower 30‐day mortality (OR 0.51, p = 0.04). On stratified analysis, neoadjuvant chemotherapy was not associated with differences in any outcomes. However, neoadjuvant CRT was associated with improvement in R0 resection (OR 3.52, <0.001) and median survival (47.8 vs. 25.3 months, log‐rank < 0.001) compared to surgery first.Conclusions: NAT, particularly neoadjuvant CRT, was associated with improved postoperative outcomes. These data suggest expanding the use of neoadjuvant CRT for eCCA.


  • A National Mixed-Methods Evaluation of General Surgery Residency Program Responsiveness and the Association with Resident Wellness

    by Rachel H. Joung, Daniela Amortegui, Casey M. Silver, Natalia I. Mackiewicz, Joshua S. Eng, Kari M. Rosenkranz, Julie Johnson, Karl Y. Bilimoria, Yue-Yung Hu


  • COVID-19 Positivity Following an In-Person Surgical Society Meeting: A Cross-Sectional Survey Study

    by Casey M. Silver, Rachel H. Joung, Michael R. Visenio, Tracy S. Wang, Timothy M. Pawlik, Eugene S. Kim, Karl Y. Bilimoria